Digestive Disease Week 2023: Cedars-Sinai Experts Share Latest Research, Care Innovations
Studies Presented by Cedars-Sinai Investigators Include: Risks of Artificial Sweeteners, Pancreatic Cancer Immunotherapy, Fibrosis in Liver and Inflammatory Bowel Disease, Obesity Management and Rise in Anal Cancer Among Women
Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. DDW2023 will take place May 6-9 in Chicago and showcase 3,100 abstracts and hundreds of lectures on the latest advances in GI research, clinical practice and technology.
Cedars-Sinai physicians and scientists will be on hand to share their latest research and are also available to comment on a wide variety of clinical and scientific developments in the field of digestive diseases.
The studies below are a sample of more than 60 papers by Cedars-Sinai investigators covering irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), digestive system cancers, the role of sex differences in disease and the use of AI technology to improve diagnosis.
Interviews can be arranged to be done in person or via most virtual formats, including Zoom, FaceTime and Skype. For more information or to set up interviews about Cedars-Sinai presentations with experts in digestive diseases, please contact Laura Coverson by phone at 310-562-1112 or by email: Laura.Coverson@cshs.org.
DDW2023 Embargo Policy: All information presented at DDW, including poster presentations, is embargoed until 12:01 a.m. CDT on the day of the presentation, unless otherwise noted.
All times for DDW2023 events and presentations are Central Time (CDT).
SATURDAY, MAY 6
Biliary Tract Diseases
Wilms Tumor 1 Promotes the Bridging Fibrosis Formation Through the Invasive Hepatic Stellate Cell Induction in Liver Fibrosis
Ekihiro Seki, MD, PhD
Translating Evidence Into Quality in Inflammatory Bowel Disease
Clinical Symposium−10:45-11 a.m.
Gil Melmed, MD Follow on Twitter @GilMelmedMD
SUNDAY, MAY 7
Immunotherapy Significantly Improves Survival in Patients With Stage IV Pancreatic Ductal Adenocarcinoma (PDAC): Results From the National Cancer Database
Yi Jiang, MD, Srinivas Gaddam, MD, MPH > Follow on Twitter @SriGaddamMD
Modeling the Role of the Intestinal Epithelium in Intestinal Fibrosis Using iPSC-Derived Human Intestinal Organoids Generated From Crohn’s Disease Patients
Christian E. Wong Valencia, PhD, Robert Barrett, PhD
Obesity & Nutrition
Economics of Obesity Management
Brennan Spiegel, MD, MSHS > Follow on Twitter @BrennanSpiegel
MONDAY, MAY 8
Microbiome in Gastrointestinal & Liver Diseases | Irritable Bowel Syndrome
The First Luminal Shotgun Sequencing of the Small Intestine Identifies Specific Strains of Escherichia and Klebsiella in SIBO Which Are Linked to Gastrointestinal Symptom Severity
Mark Pimentel, MD > Follow on Twitter @MarkPimentelMD and @MASTprogram
Microbiome in Gastrointestinal & Liver Diseases | Obesity & NutritionThe Consumption of Artificial Sweeteners Is Associated With Alterations in Microbial Communities and Their Metabolic Potential in the Small Bowel
Ava Hosseini, MPH, Ruchi Mathur, MD > Follow on Twitter @MASTprogram and @RuchiMathurMD
Inflammatory Bowel Disease
Sacroiliitis in IBD Patients: A Strong and Consistent Interaction Between HLA-B27, Gender and Crohn’s Disease/Ulcerative Colitis Status
Dalin Li, PhD, Dermot McGovern, MD, PhD > Follow on Twitter @IBDCedarsSinai
Should We Be Doing Microbiome Testing?
Suzanne Devkota, PhD > Follow on Twitter @Suzanne_Devkota
TUESDAY, MAY 9
Clinical Practice | Disparities and Quality
Increasing Trend of Anal Squamous Cell Carcinoma Incidence Rates Among White Women 2001-2019: A Population-Based Time Trend Analysis
Poster−12:30-1:30 p.m.Yazan Abboud, MD, Srinivas Gaddam, MD > Follow on Twitter @SriGaddamMD